Literature DB >> 12615863

Prevalence and mechanisms of low- and high-level mupirocin resistance in staphylococci isolated from a Korean hospital.

Hee-Jeong Yun1, Sang Won Lee, Gyu Man Yoon, Su Yeon Kim, Sooyoung Choi, Yeong Seon Lee, Eung-Chil Choi, Sunghoon Kim.   

Abstract

Mupirocin has been used against Gram-positive pathogenic bacteria, and is a specific inhibitor of bacterial isoleucyl-tRNA synthetase. In this work, we have determined the prevalence of mupirocin resistance among staphylococci isolated from a Korean hospital, and have investigated the characteristics of the resistance. In Staphylococcus aureus, the prevalence of high-level mupirocin resistance was 5% (16 of 319), whereas low-level mupirocin resistance was not detected. In coagulase-negative staphylococci (CoNS) the rates of high- and low-level mupirocin resistance were 16.7% (34 of 204) and 10.3% (21 of 204), respectively. The high-level resistant strains contained the ileS-2 gene, which encodes a novel staphylococcal isoleucyl-tRNA synthetase. In contrast, all of the low-level mupirocin-resistant CoNS contained the mutation V588F, which is located near the conserved motif KMSKS, within the chromosomal staphylococcal isoleucyl-tRNA synthetase gene (ileS). In conclusion, this work describes the recent, but rapid, emergence of two different types of mupirocin-resistant staphylococci in Korea, and the sequence and mutant characterization of the isoleucyl-tRNA synthetase of CoNS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12615863     DOI: 10.1093/jac/dkg140

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  30 in total

1.  Analysis of Antibiotic Resistance Genes and its Associated SCCmec Types among Nasal Carriage of Methicillin Resistant Coagulase Negative Staphylococci from Community Settings, Chennai, Southern India.

Authors:  Saravanan Murugesan; Nagaraj Perumal; Surya Prakash Mahalingam; Selva Kumar Dilliappan; Padma Krishnan
Journal:  J Clin Diagn Res       Date:  2015-08-01

2.  Clonal dissemination and mupA gene polymorphism of mupirocin-resistant Staphylococcus aureus isolates from long-term-care facilities in South Korea.

Authors:  Jae Il Yoo; Eun Shim Shin; Jeong Ok Cha; Jeom Kyu Lee; Young Hee Jung; Kyeong Min Lee; Bong Su Kim; Yeong Seon Lee
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

3.  Antimicrobial resistance and presence of ileS-2 gene encoding mupirocin resistance in clinical isolates of methicillin-resistant Staphylococcus sp.

Authors:  E Szczuka; A Kaznowski; K Bosacka; E Strzemieczna
Journal:  Folia Microbiol (Praha)       Date:  2009-05-06       Impact factor: 2.099

Review 4.  Current and Emerging Topical Antibacterials and Antiseptics: Agents, Action, and Resistance Patterns.

Authors:  Deborah A Williamson; Glen P Carter; Benjamin P Howden
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

5.  Emergence of methicillin-resistant Staphylococcus aureus ST239 with high-level mupirocin and inducible clindamycin resistance in a tertiary care center in Chennai, South India.

Authors:  Nagarajan Abimanyu; Saravanan Murugesan; Padma Krishnan
Journal:  J Clin Microbiol       Date:  2012-08-01       Impact factor: 5.948

6.  Phenotypic and genotypic mupirocin resistance among Staphylococci causing prosthetic joint infection.

Authors:  Margalida Rotger; Andrej Trampuz; Kerryl E Piper; James M Steckelberg; Robin Patel
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

7.  Antibacterial activity of REP8839, a new antibiotic for topical use.

Authors:  Ian A Critchley; Casey L Young; Kimberley C Stone; Urs A Ochsner; Joseph Guiles; Ted Tarasow; Nebojsa Janjic
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

8.  Emergence of ileS2-Carrying, Multidrug-Resistant Plasmids in Staphylococcus lugdunensis.

Authors:  Pak-Leung Ho; Melissa Chun-Jiao Liu; Kin-Hung Chow; Cindy Wing-Sze Tse; Wai-U Lo; Siu-Ka Mak; Wai-Kei Lo
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

9.  In vitro and in vivo evaluations of the activities of lauric acid monoester formulations against Staphylococcus aureus.

Authors:  Mark S Rouse; Margalida Rotger; Kerryl E Piper; James M Steckelberg; Matthew Scholz; Jeffrey Andrews; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

10.  Molecular analysis of isoleucyl-tRNA synthetase mutations in clinical isolates of methicillin-resistant Staphylococcus aureus with low-level mupirocin resistance.

Authors:  Jin Ah Yang; Dae Won Park; Jang Wook Sohn; In Seok Yang; Kyung Hyun Kim; Min Ja Kim
Journal:  J Korean Med Sci       Date:  2006-10       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.